U.S. Supreme Court Declines To Review Order That Certified National TPP Class

( March 23, 2026, 2:06 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court announced on March 23 that it will not consider a petition for a writ of certiorari filed by two drug companies that argued the Ninth Circuit U.S. Court of Appeals erred in certifying a national third-party payer (TPP) class of entities that paid for the diabetes drug Actos....

Attached Documents

Related Sections